Literature DB >> 25136706

Bortezomib, lenalidomide and dexamethasone (VRD) combination as salvage therapy in refractory angioimmunoblastic T cell lymphoma.

Driss Chaoui, Sonia Bouallegue, Nina Arakelyan, Philippe Genet, Ahmad Aljijakli, Laurent Sutton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25136706     DOI： 10.1111/bjh.12678

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

1.  Re-invigorating rather than re-inventing the wheel: augmenting the impact of salvage autologous stem cell transplantation for multiple myeloma in the era of novel agents.

Authors:  G Cook
Journal:  Bone Marrow Transplant       Date:  2015-08-03       Impact factor: 5.483

2.  Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.

Authors:  Yu Ma; Ziwei Liao; Yi Xu; Ziyun Zhong; Xu Wang; Fan Zhang; Shaohua Chen; Lijian Yang; Gengxin Luo; Xin Huang; Suming Huang; Xiuli Wu; Yangqiu Li
Journal:  Eur J Med Res       Date:  2014-11-11       Impact factor: 2.175
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.